HUP0203052A3 - Bicyclic imidazo-3-yl-amine derivatives, process for their preparation, pharmaceutical compositions containing them and their use - Google Patents

Bicyclic imidazo-3-yl-amine derivatives, process for their preparation, pharmaceutical compositions containing them and their use

Info

Publication number: HUP0203052A3
Authority: HU; Hungary
Prior art keywords: preparation; pharmaceutical compositions; compositions containing; amine derivatives; bicyclic imidazo
Prior art date: 1999-10-08

Application number

HU0203052A

Other languages

English (en)

Original Assignee

Gruenenthal Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-08

Filing date

2000-09-18

Publication date

2004-06-28

1999-10-08 Priority claimed from DE1999148438 external-priority patent/DE19948438B4/de

1999-10-08 Priority claimed from DE19948434A external-priority patent/DE19948434A1/de

2000-09-18 Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh

2003-01-28 Publication of HUP0203052A2 publication Critical patent/HUP0203052A2/hu

2004-06-28 Publication of HUP0203052A3 publication Critical patent/HUP0203052A3/hu

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Anesthesiology (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

HU0203052A 1999-10-08 2000-09-18 Bicyclic imidazo-3-yl-amine derivatives, process for their preparation, pharmaceutical compositions containing them and their use HUP0203052A3 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE1999148438 DE19948438B4 (de)	1999-10-08	1999-10-08	Bicyclische Imidazo-3-aminderivate
DE19948434A DE19948434A1 (de)	1999-10-08	1999-10-08	Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine
PCT/EP2000/009096 WO2001027111A2 (de)	1999-10-08	2000-09-18	Bicyclische imidazo-3-yl-aminderivate

Publications (2)

Publication Number	Publication Date
HUP0203052A2 HUP0203052A2 (hu)	2003-01-28
HUP0203052A3 true HUP0203052A3 (en)	2004-06-28

Family

ID=26055218

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU0203052A HUP0203052A3 (en)	1999-10-08	2000-09-18	Bicyclic imidazo-3-yl-amine derivatives, process for their preparation, pharmaceutical compositions containing them and their use

Country Status (26)

Country	Link
US (1)	US6638933B2 (hu)
EP (1)	EP1218382B1 (hu)
JP (1)	JP2003511451A (hu)
KR (1)	KR100756592B1 (hu)
CN (1)	CN1257169C (hu)
AR (1)	AR025962A1 (hu)
AT (1)	ATE258554T1 (hu)
AU (1)	AU779197B2 (hu)
BR (1)	BR0014818A (hu)
CA (1)	CA2382919C (hu)
CO (1)	CO5251378A1 (hu)
CZ (1)	CZ20021210A3 (hu)
DE (1)	DE50005155D1 (hu)
DK (1)	DK1218382T3 (hu)
ES (1)	ES2213611T3 (hu)
HK (1)	HK1047747B (hu)
HU (1)	HUP0203052A3 (hu)
NO (1)	NO322754B1 (hu)
NZ (2)	NZ518390A (hu)
PE (1)	PE20010634A1 (hu)
PL (1)	PL355206A1 (hu)
PT (1)	PT1218382E (hu)
RU (1)	RU2264402C2 (hu)
SK (1)	SK286788B6 (hu)
UY (1)	UY26372A1 (hu)
WO (1)	WO2001027111A2 (hu)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040077605A1 (en) *	2001-06-20	2004-04-22	Salvati Mark E.	Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
DE10043845A1 (de) *	2000-09-06	2002-03-14	Gruenenthal Gmbh	Verfahren zur Messung der Aktivität der NO-Synthase
EP1854798A3 (en)	2000-09-19	2007-11-28	Bristol-Myers Squibb Company	Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
WO2002048146A2 (de) *	2000-12-13	2002-06-20	Basf Aktiengesellschaft	Verwendung von substituierten imidazoazinen, neue imidazoazine, verfahren zu deren herstellung, sowie sie enthaltende mittel
US20040087548A1 (en)	2001-02-27	2004-05-06	Salvati Mark E.	Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
AU2002364082A1 (en)	2001-12-19	2003-07-09	Bristol-Myers Squibb Company	Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
DE102004021716A1 (de) *	2004-04-30	2005-12-01	Grünenthal GmbH	Substituierte Imidazo[1,2-a]pyridin-Verbindungen und Arzneimittel enthaltend substituierte Imidazo[1,2-a]pyridin-Verbindungen
WO2006131003A1 (en) *	2005-06-09	2006-12-14	Oncalis Ag	Angiogenesis inhibitors
DE602005013085D1 (de) *	2004-06-09	2009-04-16	Oncalis Ag	Proteinkinaseinhibitoren
US7923041B2 (en) *	2005-02-03	2011-04-12	Signum Biosciences, Inc.	Compositions and methods for enhancing cognitive function
KR100973609B1 (ko) *	2005-03-23	2010-08-03	에프. 호프만-라 로슈 아게	ｍＧｌｕＲ2 길항제로서 아세틸렌일-피라졸로-피리미딘유도체
CN101263142A (zh) *	2005-05-20	2008-09-10	阿雷生物药品公司	Raf抑制剂化合物及其使用方法
US7709468B2 (en)	2005-09-02	2010-05-04	Abbott Laboratories	Imidazo based heterocycles
BRPI0620760A2 (pt) *	2005-12-27	2011-11-22	Hoffmann La Roche	derivados de aril-isoxazol-4-il-imidazo[1,5]piridina
BRPI0706560A2 (pt) *	2006-01-17	2011-03-29	Hoffmann La Roche	derivados de aril-isoxazol-4-il-imidazo [1,2-a] piridina úteis para o tratamento de doença de alzheimer por intermédio de receptores gaba
EP1845098A1 (en) *	2006-03-29	2007-10-17	Ferrer Internacional, S.A.	Imidazo[1,2-b]pyridazines, their processes of preparation and their use as GABA receptor ligands
KR20090026288A (ko) *	2006-05-31	2009-03-12	갈라파고스 엔.브이.	퇴행성 및 염증성 질환의 치료에 유용한 트리아졸로피라진 화합물
US8227603B2 (en) *	2006-08-01	2012-07-24	Cytokinetics, Inc.	Modulating skeletal muscle
WO2008016648A2 (en) *	2006-08-01	2008-02-07	Cytokinetics, Incorporated	Certain chemical entities, compositions and methods
JP5249217B2 (ja) *	2006-08-02	2013-07-31	サイトキネティクス・インコーポレーテッド	特定の化学物質、組成物及び方法
US8299248B2 (en)	2006-08-02	2012-10-30	Cytokinetics, Incorporated	Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
EP1974729A1 (en) *	2007-03-28	2008-10-01	Santhera Pharmaceuticals (Schweiz) AG	Substituted imidazopyridine derivates as melanocortin- 4 receptor antagonists
WO2008121333A1 (en) *	2007-03-30	2008-10-09	Cytokinetics, Incorporated	Certain chemical entities, compositions and methods
GB0708188D0 (en) *	2007-04-27	2007-06-06	Merck Sharp & Dohme	Therapeutic compounds
PL2266990T3 (pl) *	2008-04-15	2013-03-29	Eisai R&D Man Co Ltd	ZWIĄZEK 3-FENYLOPIRAZOLO[5,1-b] TIAZOLOWY
AU2009268406A1 (en) *	2008-07-10	2010-01-14	Southern Research Institute	5-Quinolinone and Imidazopyridine compounds and use thereof
EP2334675B1 (en) *	2008-09-16	2014-03-26	Csir	Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors
CN105219734B (zh)	2008-12-05	2020-03-03	武田疫苗公司	用于诱导病毒生长的组合物、方法和用途
AR078521A1 (es) *	2009-10-08	2011-11-16	Eisai R&D Man Co Ltd	Compuesto pirazolotiazol
EP2731611B1 (en)	2011-07-13	2019-09-18	Cytokinetics, Inc.	Combination therapie for als
BR112015010469A2 (pt) *	2012-11-14	2017-07-11	Hoffmann La Roche	derivados de imidazopiridina
SG11201507224RA (en) *	2013-03-14	2015-10-29	Galapagos Nv	Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
WO2017160922A1 (en)	2016-03-16	2017-09-21	Kalyra Pharmaceuticals, Inc.	Analgesic compounds
EP3615532A4 (en) *	2017-04-28	2020-11-18	Dana Farber Cancer Institute, Inc.	TRIM33 INHIBITORS AND METHODS OF USE
WO2019070943A1 (en) *	2017-10-04	2019-04-11	Dana-Farber Cancer Institute, Inc.	SMALL MOLECULE INHIBITION OF SALL4 TRANSCRIPTION FACTOR AND USES THEREOF

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0068378B1 (en)	1981-06-26	1986-03-05	Schering Corporation	Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
NZ221996A (en) *	1986-10-07	1989-08-29	Yamanouchi Pharma Co Ltd	Imidazo-pyridine derivatives and pharmaceutical compositions
RU2043716C1 (ru) *	1989-06-23	1995-09-20	Такеда Кемикал Индастриз Лтд.	Амидное производное и фунгицидный состав на его основе
NZ238863A (en) *	1990-07-19	1993-03-26	Janssen Pharmaceutica Nv	Substituted thiazolyl and pyridinyl derivatives
TW274551B (hu) *	1991-04-16	1996-04-21	Takeda Pharm Industry Co Ltd
DE4327027A1 (de) *	1993-02-15	1994-08-18	Bayer Ag	Imidazoazine
KR19990007836A (ko) *	1995-04-21	1999-01-25	다나까 테츠오	융합된 이미다조[1, 2-a]피리딘
AU2001270297A1 (en) *	2000-06-30	2002-01-14	Neurogen Corporation	2-phenylimidazo(1,2-a)pyridine derivatives: a new class of gaba brain receptor ligands

2000
- 2000-09-18 AU AU77771/00A patent/AU779197B2/en not_active Ceased
- 2000-09-18 SK SK436-2002A patent/SK286788B6/sk not_active IP Right Cessation
- 2000-09-18 ES ES00967692T patent/ES2213611T3/es not_active Expired - Lifetime
- 2000-09-18 PT PT00967692T patent/PT1218382E/pt unknown
- 2000-09-18 BR BR0014818-0A patent/BR0014818A/pt not_active Application Discontinuation
- 2000-09-18 PL PL00355206A patent/PL355206A1/xx not_active IP Right Cessation
- 2000-09-18 NZ NZ518390A patent/NZ518390A/en unknown
- 2000-09-18 NZ NZ518439A patent/NZ518439A/en unknown
- 2000-09-18 CN CNB008159866A patent/CN1257169C/zh not_active Expired - Fee Related
- 2000-09-18 KR KR1020027004516A patent/KR100756592B1/ko not_active Expired - Fee Related
- 2000-09-18 CZ CZ20021210A patent/CZ20021210A3/cs unknown
- 2000-09-18 CA CA002382919A patent/CA2382919C/en not_active Expired - Fee Related
- 2000-09-18 WO PCT/EP2000/009096 patent/WO2001027111A2/de not_active Ceased
- 2000-09-18 AT AT00967692T patent/ATE258554T1/de active
- 2000-09-18 HK HK02109382.5A patent/HK1047747B/zh not_active IP Right Cessation
- 2000-09-18 JP JP2001530329A patent/JP2003511451A/ja not_active Withdrawn
- 2000-09-18 RU RU2002110102/04A patent/RU2264402C2/ru not_active IP Right Cessation
- 2000-09-18 HU HU0203052A patent/HUP0203052A3/hu unknown
- 2000-09-18 EP EP00967692A patent/EP1218382B1/de not_active Expired - Lifetime
- 2000-09-18 DK DK00967692T patent/DK1218382T3/da active
- 2000-09-18 DE DE50005155T patent/DE50005155D1/de not_active Expired - Lifetime
- 2000-10-05 UY UY26372A patent/UY26372A1/es not_active Application Discontinuation
- 2000-10-05 CO CO00075814A patent/CO5251378A1/es not_active Application Discontinuation
- 2000-10-05 AR ARP000105254A patent/AR025962A1/es unknown
- 2000-10-06 PE PE2000001064A patent/PE20010634A1/es not_active Application Discontinuation
2002
- 2002-04-03 NO NO20021565A patent/NO322754B1/no not_active IP Right Cessation
- 2002-04-08 US US10/117,333 patent/US6638933B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
SK4362002A3 (en)	2002-08-06
ATE258554T1 (de)	2004-02-15
PE20010634A1 (es)	2001-07-07
WO2001027111A3 (de)	2001-06-14
ES2213611T3 (es)	2004-09-01
CO5251378A1 (es)	2003-02-28
CN1391573A (zh)	2003-01-15
KR100756592B1 (ko)	2007-09-10
AU779197B2 (en)	2005-01-13
NO20021565L (no)	2002-05-27
JP2003511451A (ja)	2003-03-25
NZ518439A (en)	2003-10-31
SK286788B6 (sk)	2009-05-07
CA2382919A1 (en)	2001-04-19
BR0014818A (pt)	2002-06-18
UY26372A1 (es)	2000-12-29
CN1257169C (zh)	2006-05-24
EP1218382B1 (de)	2004-01-28
AR025962A1 (es)	2002-12-26
US20030018032A1 (en)	2003-01-23
HUP0203052A2 (hu)	2003-01-28
DE50005155D1 (de)	2004-03-04
US6638933B2 (en)	2003-10-28
PL355206A1 (en)	2004-04-05
CZ20021210A3 (cs)	2002-08-14
HK1047747B (zh)	2004-12-03
NO322754B1 (no)	2006-12-04
NZ518390A (en)	2003-10-31
NO20021565D0 (no)	2002-04-03
EP1218382A2 (de)	2002-07-03
PT1218382E (pt)	2004-06-30
HK1047747A1 (zh)	2003-03-07
DK1218382T3 (da)	2004-03-22
CA2382919C (en)	2008-12-09
RU2264402C2 (ru)	2005-11-20
KR20020038805A (ko)	2002-05-23
WO2001027111A2 (de)	2001-04-19
AU7777100A (en)	2001-04-23

Publication	Publication Date	Title
HUP0203052A3 (en)	2004-06-28	Bicyclic imidazo-3-yl-amine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0300618A3 (en)	2003-12-29	Adamantana derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0204245A3 (en)	2004-12-28	Novel n-azabicyclo-amide derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0203294A3 (en)	2003-03-28	Benzodiazepine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0203548A3 (en)	2003-04-28	New spirooxindole derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0203316A3 (en)	2004-07-28	Amino-triazolopyridine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0203142A3 (en)	2003-03-28	Benzodiazepine derivatives, process for preparation of the compounds, pharmaceutical compositions containing them and their use
HUP0105114A3 (en)	2002-09-30	Quinazolinone derivatives, pharmaceutical compositions containing them, their use and process for their preparation
HUP0204515A3 (en)	2005-04-28	4-aminopiperidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0200396A3 (en)	2003-04-28	Gluckokinase activators, process for their preparation, pharmaceutical compositions containing them and their use
HUP0300616A3 (en)	2004-08-30	Adamantane derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0204410A3 (en)	2003-07-28	Pyrimidine-4-one derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0202731A3 (en)	2003-10-28	O-anisamide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0202100A3 (en)	2003-09-29	Novel quinuclidine derivatives, process for their preparation and medicinal compositions containing the same
HUP0204226A3 (en)	2003-07-28	Quinazoline derivatives, pharmaceutical compositions containing them, their use and process for the preparation of the compounds
HUP0203140A3 (en)	2004-06-28	Bicyclic imidazo-5-yl-amine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0201516A3 (en)	2003-03-28	13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0201753A3 (en)	2004-12-28	Pyridopyranoazepine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0202075A3 (en)	2003-03-28	Substituted 2-dialkylaminoalkylbiphenyl derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0203184A3 (en)	2004-12-28	Isoxazolecarboxamide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0203385A3 (en)	2003-07-28	Pyrimidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0201402A3 (en)	2003-12-29	Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them
HUP0201315A3 (en)	2003-02-28	4-phenyl-pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0400317A3 (en)	2007-10-29	Beta-carboline derivatives, process for their preparation, their use and pharmaceutical compositions containing them
IL147248A0 (en)	2002-08-14	Naphthyridine derivatives, process for their preparation, their use and pharmaceutical compositions comprising them

Legal Events

Date	Code	Title	Description
2010-05-28	FA9A	Lapse of provisional patent protection due to relinquishment or protection considered relinquished